Asarina Pharma AB (publ) (”the Company”) announces today that the Board has decided to postpone the release of the Annual Report for 2023 to June 4th, 2024.
The release is postponed as the Company is still working with its auditors to resolve the last outstanding points in the Annual Report.
For additional information, please contact:
Jakob Dynnes Hansen, CFO, Asarina Pharma AB
Telefon: +45 5132 3698
E-post: jakob.dynnes@asarinapharma.com
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).